Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
83.50    -0.50 (-0.60%)
Bid:
82.00
Ask:
85.00
Spread: 3.00 (3.659%)
Market Cap: £12.11m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Acquisition

6 Feb 2007 07:00

Adventis Group PLC06 February 2007 For release at 07.00 Feb 6th 2007 ADVENTIS GROUP PLC ACQUISITION OF LEAPFROG MEDICAL COMMUNICATIONS LTD Adventis Group plc ( "Adventis" or the "Company", ticker ATG), the specialistmultimedia and marketing group, is pleased to announce that it has acquiredLeapFrog Medical Communications Limited ("LeapFrog"), a leading medicaleducation company, for a total maximum consideration of £2.65 million. The total consideration will be satisfied by the payment of initialconsideration of £1.306 million, payable as to £0.874 million in cash and £0.432million by the issue of 975,169 new ordinary shares in Adventis ("New OrdinaryShares"), and by deferred consideration of £0.72 million payable in tranches of£0.24 million on each of the first, second and third anniversaries of theacquisition. Each deferred consideration tranche will be satisfied as to 60 percent in cash and as to 40 per cent payable in new ordinary shares in Adventis.There is further deferred consideration payable of up to £0.624 million, basedon the achievement of certain profit growth related criteria over the followingthree years to be satisfied annually according to performance as to 50 per centin cash and 50 per cent payable in new ordinary shares in Adventis. LeapFrog, whose clients include, GSK, Pfizer, MSD, Roche and Novartis, wasestablished in 2001. It provides a range of medical education programmes to thehealthcare industry, promotional aids for sales representatives and alsoinitiates PR campaigns aimed at healthcare professionals and consumers forimproving clients' product brand awareness. For the year ended 30 November 2006,LeapFrog reported audited turnover of approximately £1.57 million and pre-taxprofit of approximately £0.39 million. Net assets at that date amounted toapproximately £0.25 million. Tim Schofield and Gail Rowe, LeapFrog's principaldirectors, will remain with the company following the acquisition. The acquisition will create one of the industry's top three pharmaceuticalindustry service providers, becoming part of an enlarged Healthcare servicesdivision embracing Affiniti Advertising, acquired in 2005, and RoundhouseHealthAd, acquired in 2006. The addition of LeapFrog to Affiniti and Roundhouse creates a formidable,award-winning team in the Adventis Healthcare division, with over 50 employeesworking in centralised premises in the Thames Valley. The enlarged Healthcareservices operations, whose other clients include Boehringer Ingelheim, Allergan,Baxter and Merck Serono, will have the capability to provide a complete range ofintegrated marketing services, from medical education, to advertising to newmedia. It will also provide the opportunity for an increased level ofcross-selling and the ability to provide multinational clients with a greaterlocal understanding of target markets service. Application has been made for the admission to AIM of the New Ordinary Shares,which will rank pari passu with the Company's existing issued ordinary shares,and dealings are expected to commence on 9th February 2007. Charles Phillpot, CEO, Adventis Group, said: "We will now be one of the fewcompanies in the industry to offer a full service marketing capability and theability to handle larger and more complex campaigns for clients. We are nowamong the top three players in two of our three chosen market sectors." Tim Schofield and Gail Rowe said: "We see joining forces with the two topcreative agencies in our industry as a unique way of adding value to ourclients. Being able to address their various needs within one group will be atremendous bonus for us all." ENDS Enquiries: Adventis Group Plc Charles Phillpot, CEO 020 7034 4750 Peter Linnell, Finance Director & Company Secretary 020 7034 4795 Adventis Financial PR Chris Steele 020 7034 4759 Peter Binns 020 7034 4760 Editor's Note: Adventis Group plc, provides a complete range of communications services,including corporate identity programmes, advertising campaigns, media andplanning and buying, literature, public relations, packaging, exhibitions,research and planning, interiors signage and digital media. The group employs145 staff in London and the southeast. Adventis has two other divisions focusing on providing a range of services tothe property and financial sectors. Adventis Group was admitted to AIM in 2004,mainly operating as a media and marketing services provider to the propertysector. LeapFrog becomes the group's ninth operating company. www.adventis.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSWest Newton Flow Rate Update
23rd Dec 20217:00 amRNSVictory – Submission of Draft FDP
2nd Dec 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20217:00 amRNSWest Newton – Rathlin’s Update to Residents
22nd Oct 20217:00 amRNSDirectors’ Dealings
21st Oct 20217:00 amRNSCreation of Enhanced California E&P Company
20th Oct 202111:05 amRNSSecond Price Monitoring Extn
20th Oct 202111:00 amRNSPrice Monitoring Extension
20th Oct 20217:00 amRNSVictory CPR and Corallian Strategic Review
13th Oct 20217:00 amRNSWest Newton Well Test Operations Update
4th Oct 202111:00 amRNSPrice Monitoring Extension
1st Oct 20217:00 amRNSWest Newton A Site Planning Decision
30th Sep 20214:05 pmRNSUnaudited Interim Results 6months ended 30 June 21
31st Aug 20217:00 amRNSWest Newton Operations Update
28th Jul 20213:52 pmRNSResults of AGM
21st Jul 20217:00 amRNSWest Newton Operations Update
25th Jun 20217:00 amRNSEnvironmental Baseline Survey Completed at Victory
23rd Jun 20217:00 amRNSNotice of Annual General Meeting
21st Jun 20217:00 amRNSExtension of Parta Exploration Licence in Romania
10th Jun 20217:00 amRNSFull Year Results for the year ended 31 Dec 2020
25th May 20217:00 amRNSWest Newton Operations Update
19th May 20217:00 amRNSTR-1
14th May 20218:15 amRNSTotal Voting Rights
10th May 20217:00 amRNSCompletion of Offer to Acquire Shares of Corallian
10th May 20217:00 amRNSWest Newton CPR
27th Apr 20217:00 amRNSConditional Offer to Acquire Shares in Corallian
20th Apr 20217:00 amRNSWest Newton Operations Update
30th Mar 20217:00 amRNSWest Newton Test Programme Update
22nd Mar 20217:00 amRNSWest Newton Online Consultation Launched
3rd Mar 20217:00 amRNSPartial Sale of Convertible Loan Notes
26th Feb 20213:00 pmRNSAmendment of Existing Option Terms
24th Feb 20213:01 pmRNSConfirmation of increased investment in Corallian
23rd Feb 20214:30 pmRNSHolding(s) in Company
22nd Feb 20217:00 amRNSIncreased investment in Corallian
3rd Feb 20217:00 amRNSLive Investor Q&A
1st Feb 20218:15 amRNSTotal Voting Rights & Director Disclosure
28th Jan 20213:59 pmRNSDirectors’ Dealings
28th Jan 20217:00 amRNSFundraise of £7.5 million
22nd Jan 20217:00 amRNSWest Newton A Site Planning Update
29th Dec 20207:00 amRNSStandard form for notification of major holdings
17th Dec 20209:38 amRNSStandard form for notification of major holdings
10th Dec 20207:00 amRNSSignificant Hydrocarbon Discovery at West Newton
1st Dec 20207:00 amRNSExercise of Warrants in Corallian
23rd Nov 20207:00 amRNSWest Newton B-1 Operations Update
17th Nov 20207:00 amRNSVictory Gas Discovery Presentation
5th Oct 20207:00 amRNSAppraisal Drilling Commences at West Newton
23rd Sep 202012:20 pmRNSResult of AGM
23rd Sep 20207:00 amRNSInterim Results for 6 months ended 30 June 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.